Paul Gallant

3.8k total citations
11 papers, 620 citations indexed

About

Paul Gallant is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Paul Gallant has authored 11 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Genetics. Recurrent topics in Paul Gallant's work include RNA and protein synthesis mechanisms (8 papers), RNA modifications and cancer (3 papers) and Chemical Synthesis and Analysis (2 papers). Paul Gallant is often cited by papers focused on RNA and protein synthesis mechanisms (8 papers), RNA modifications and cancer (3 papers) and Chemical Synthesis and Analysis (2 papers). Paul Gallant collaborates with scholars based in United States, Switzerland and Japan. Paul Gallant's co-authors include Edward Maliski, Xiaoyang Xia, David Rogers, Dennis D. Keith, John Finn, Janice E. Kranz, Paul Schimmel, Mandana Sassanfar, Kiyotaka Shiba and Ximao Wu and has published in prestigious journals such as Biochemistry, Journal of Medicinal Chemistry and Plant Molecular Biology.

In The Last Decade

Paul Gallant

11 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Gallant United States 10 404 215 161 63 51 11 620
Amin Mirza United Kingdom 15 399 1.0× 152 0.7× 229 1.4× 52 0.8× 63 1.2× 21 738
Christopher J. Sherman United States 4 444 1.1× 387 1.8× 171 1.1× 48 0.8× 41 0.8× 4 636
Chris Waller United States 9 378 0.9× 447 2.1× 183 1.1× 62 1.0× 50 1.0× 14 773
Fabiana Caporuscio Italy 18 344 0.9× 267 1.2× 276 1.7× 66 1.0× 96 1.9× 24 791
Kathryn Loving United States 6 292 0.7× 182 0.8× 75 0.5× 46 0.7× 47 0.9× 7 441
Francesca Perruccio United Kingdom 10 425 1.1× 217 1.0× 104 0.6× 67 1.1× 47 0.9× 12 636
Michał Łaźniewski Poland 14 537 1.3× 265 1.2× 90 0.6× 66 1.0× 66 1.3× 23 823
Simon Cross Italy 15 433 1.1× 332 1.5× 123 0.8× 127 2.0× 68 1.3× 27 738
Oranit Dror Israel 10 531 1.3× 225 1.0× 92 0.6× 51 0.8× 38 0.7× 11 714
Manuela S. Murgueitio Germany 14 402 1.0× 273 1.3× 68 0.4× 65 1.0× 36 0.7× 19 742

Countries citing papers authored by Paul Gallant

Since Specialization
Citations

This map shows the geographic impact of Paul Gallant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Gallant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Gallant more than expected).

Fields of papers citing papers by Paul Gallant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Gallant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Gallant. The network helps show where Paul Gallant may publish in the future.

Co-authorship network of co-authors of Paul Gallant

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Gallant. A scholar is included among the top collaborators of Paul Gallant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Gallant. Paul Gallant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Deak, Holly L., John Newcomb, Joseph J. Nunes, et al.. (2007). N-(3-(Phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: Structure, synthesis and SAR. Bioorganic & Medicinal Chemistry Letters. 18(3). 1172–1176. 9 indexed citations
2.
Tandon, Manish, David L. Coffen, Paul Gallant, Dennis D. Keith, & Mark A. Ashwell. (2004). Potent and selective inhibitors of bacterial methionyl tRNA synthetase derived from an oxazolone–dipeptide scaffold. Bioorganic & Medicinal Chemistry Letters. 14(8). 1909–1911. 25 indexed citations
3.
Xia, Xiaoyang, Edward Maliski, Paul Gallant, & David Rogers. (2004). Classification of Kinase Inhibitors Using a Bayesian Model. Journal of Medicinal Chemistry. 47(18). 4463–4470. 300 indexed citations
4.
Finn, John, et al.. (2003). Discovery of a potent and selective series of pyrazole bacterial methionyl-tRNA synthetase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(13). 2231–2234. 62 indexed citations
5.
Finn, John M., et al.. (2003). Discovery of a Potent and Selective Series of Pyrazole Bacterial Methionyl‐tRNA Synthetase Inhibitors.. ChemInform. 34(42). 1 indexed citations
6.
Yu, Xiang, Jason M. Hill, Guixue Yu, et al.. (2001). A series of quinoline analogues as potent inhibitors of C. albicans prolyl tRNA synthetase. Bioorganic & Medicinal Chemistry Letters. 11(4). 541–544. 30 indexed citations
7.
Hyde‐DeRuyscher, Robin, et al.. (2000). Detection of small-molecule enzyme inhibitors with peptides isolated from phage-displayed combinatorial peptide libraries. Chemistry & Biology. 7(1). 17–25. 77 indexed citations
8.
9.
Yu, Xiang, et al.. (1999). Synthesis and structure-activity relationships of a series of novel thiazoles as inhibitors of aminoacyl-tRNA synthetases. Bioorganic & Medicinal Chemistry Letters. 9(3). 375–380. 29 indexed citations
10.
Tague, Brian W., Paul Gallant, & Howard M. Goodman. (1996). Expression analysis of an Arabidopsis C2H2 zinc finger protein gene. Plant Molecular Biology. 32(5). 785–796. 16 indexed citations
11.
Sassanfar, Mandana, Janice E. Kranz, Paul Gallant, Paul Schimmel, & Kiyotaka Shiba. (1996). A Eubacterial Mycobacterium tuberculosis tRNA Synthetase Is Eukaryote-like and Resistant to a Eubacterial-Specific Antisynthetase Drug. Biochemistry. 35(31). 9995–10003. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amin Mirza Breakdown of academic impact, for papers by Christopher J. Sherman Breakdown of academic impact, for papers by Chris Waller Breakdown of academic impact, for papers by Fabiana Caporuscio Breakdown of academic impact, for papers by Kathryn Loving Breakdown of academic impact, for papers by Francesca Perruccio Breakdown of academic impact, for papers by Michał Łaźniewski Breakdown of academic impact, for papers by Simon Cross Breakdown of academic impact, for papers by Oranit Dror Breakdown of academic impact, for papers by Manuela S. Murgueitio
Rankless by CCL
2026